Beeline Medicines: Funding, Investors & Team (Sep 2026)
Beeline Medicines is a biotechnology company that identifies and provides precise treatments to autoimmune inflammatory disorders.
Beeline Medicines has raised $426M across 2 funding rounds on record, the most recent a Series A of $126M announced in Jun 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Beeline Medicines Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Beeline Medicines Funding Rounds
Beeline Medicines raised $300M in a Series A announced in Apr 2026.
2 months later, a Series A of $126M was announced in Jun 2026.
Beeline Medicines Founders and Leadership Team
No contact details are on record for this team yet.
Beeline Medicines Funding Compared to Other Biotechnology Startups
Beeline Medicines' latest round of $126M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Beeline Medicines in Biotechnology and Boston
Companies Similar to Beeline Medicines
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Beeline Medicines Funding FAQs
What does Beeline Medicines do?
Beeline Medicines is a biotechnology company that identifies and provides precise treatments to autoimmune inflammatory disorders.
How much funding has Beeline Medicines raised?
Beeline Medicines has raised $426M across 2 rounds on record. The most recent is a Series A of $126M announced in Jun 2026.
When did Beeline Medicines last raise funding?
Beeline Medicines' most recent funding round on record is a Series A of $126M, announced in Jun 2026.
Who founded Beeline Medicines?
FundedIQ lists Saqib Islam (Founder) at Beeline Medicines.
Where is Beeline Medicines headquartered?
Beeline Medicines is based in Boston, Massachusetts, United States.
How many employees does Beeline Medicines have?
Beeline Medicines is in the 11-50 employee band.
How does Beeline Medicines' funding compare to other Biotechnology startups?
Beeline Medicines' latest round of $126M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Beeline Medicines Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Beeline Medicines is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.